Synthesis of malarial plasmepsin inhibitors and prediction of binding modes by molecular dynamics simulations

被引:58
作者
Ersmark, K
Nervall, M
Hamelink, E
Janka, LK
Clemente, JC
Dunn, BM
Blackman, MJ
Samuelsson, B
Aqvist, J
Hallberg, A
机构
[1] Uppsala Univ, BMC, Dept Med Chem, S-75123 Uppsala, Sweden
[2] Uppsala Univ, Dept Cell & Mol Biol, S-75124 Uppsala, Sweden
[3] Natl Inst Med Res, Div Parasitol, London NWI 1AA, England
[4] Univ Florida, Coll Med, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA
基金
英国医学研究理事会;
关键词
D O I
10.1021/jm050463l
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of inhibitors of the malarial aspartic proteases Plm I and II have been synthesized with L-mannitol as precursor. These inhibitors are characterized by either a diacylhydrazine or a five-membered oxadiazole ring replacing backbone amide functionalities. Molecular dynamics simulations were applied in the design process. The computationally predicted Plm II K-i values were generally in excellent agreement with the biological results. The diacylhydrazine was found to be superior over the oxadiazole as an amide bond replacement in the Plm I and II inhibitors studied. An extensive flexibility of the S2 ' pocket was captured by the simulations predicting the binding mode of the unsymmetrical inhibitors. Plm I and II inhibitors with single digit nanomolar K-i values devoid of inhibitory activity toward human Cat D were identified. One compound, lacking amide bonds, was found to be Plm IV selective and very potent, with a K-i value of 35 nM.
引用
收藏
页码:6090 / 6106
页数:17
相关论文
共 69 条
  • [1] NEW METHOD FOR PREDICTING BINDING-AFFINITY IN COMPUTER-AIDED DRUG DESIGN
    AQVIST, J
    MEDINA, C
    SAMUELSSON, JE
    [J]. PROTEIN ENGINEERING, 1994, 7 (03): : 385 - 391
  • [2] Novel uncomplexed and complexed structures of plasmepsin II, an aspartic protease from Plasmodium falciparum
    Asojo, OA
    Gulnik, SV
    Afonina, E
    Yu, B
    Ellman, JA
    Haque, TS
    Silva, AM
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 2003, 327 (01) : 173 - 181
  • [3] Structures of Ser205 mutant plasmepsin II from Plasmodium falciparum at 1.8 Å in complex with the inhibitors rs367 and rs370
    Asojo, OA
    Afonina, E
    Gulnik, SV
    Yu, B
    Erickson, JW
    Randad, R
    Medjahed, D
    Silva, AM
    [J]. ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY, 2002, 58 : 2001 - 2008
  • [4] Four plasmepsins are active in the Plasmodium falciparum food vacuole, including a protease with an active-site histidine
    Banerjee, R
    Liu, J
    Beatty, W
    Pelosof, L
    Klemba, M
    Goldberg, DE
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (02) : 990 - 995
  • [5] Berry C, 2000, Curr Opin Drug Discov Devel, V3, P624
  • [6] Computational prediction of structure, substrate binding mode, mechanism, and rate for a malaria protease with a novel type of active site
    Bjelic, S
    Åqvist, J
    [J]. BIOCHEMISTRY, 2004, 43 (46) : 14521 - 14528
  • [7] Inhibitors of the Plasmodium falciparum parasite aspartic protease plasmepsin II as potential antimalarial agents
    Boss, C
    Richard-Bildstein, S
    Weller, T
    Fischli, W
    Meyer, S
    Binkert, C
    [J]. CURRENT MEDICINAL CHEMISTRY, 2003, 10 (11) : 883 - 907
  • [8] Novel procedure for the synthesis of 1,3,4-oxadiazoles from 1,2-diacylhydrazines using polymer-supported Burgess reagent under microwave conditions
    Brain, CT
    Paul, JM
    Loong, Y
    Oakley, PJ
    [J]. TETRAHEDRON LETTERS, 1999, 40 (16) : 3275 - 3278
  • [9] BREMAN J, 2001, AM J TROP MED HYG, V64
  • [10] Identification of potent inhibitors of Plasmodium falciparum plasmepsin II from an encoded statine combinatorial library
    Carroll, CD
    Patel, H
    Johnson, TO
    Guo, T
    Orlowski, M
    He, ZM
    Cavallaro, CL
    Guo, J
    Oksman, A
    Gluzman, IY
    Connelly, J
    Chelsky, D
    Goldberg, DE
    Dolle, RE
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1998, 8 (17) : 2315 - 2320